Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 01/22/19

JoyAnn Phillips Rohan, Ph.D.

JoyAnn Phillips Rohan, Ph.D.

Program Director

Translational Research Program

Division of Cancer Treatment and Diagnosis,
National Cancer Institute
9609 Medical Center Drive, Room 3W206
MSC 9726
Bethesda, MD 20892
Phone (240) 276-5730
Fax (240) 276-5150

JoyAnn Phillips Rohan, Ph.D. is a Program Director at the Translational Research Program within the Division of Cancer Treatment and Diagnosis (DCTD) at the National Cancer Institute (NCI) managing Specialized Programs of Research Excellence (SPOREs) in breast and gynecological cancers. Dr. Rohan obtained her Ph.D. in molecular and cellular biology at Baylor College of Medicine studying the molecular mechanisms of vitamin D action in prostate cancer cells. Since then, she has served as a post-doctoral fellow for programs focused on complementary alternative medicine at Morgan State University and minority health and health disparities at Georgetown University. She served as a project manager for the Clinical Assay Development Program in the DCTD that supported investigators seeking clinical assay validation resources for assays with clinical utility. She later served as scientific program manager for the Molecular Characterization Laboratory, NCI Frederick National Laboratory for Cancer Research with Leidos Biomedical Research, Inc. (LBR) managing a network of next generation sequencing laboratories, among other activities. This NGS network supports the sequencing arm of the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) Trial that seeks to determine whether treating cancers according to their molecular abnormalities will show evidence of effectiveness. Dr. Rohan has over ten years of experiences in cancer molecular biology research and over five years of experiences in cancer-related project management for NCI and extramural communities. Eager to continue her engagement in cutting-edge translational cancer research, Dr. Rohan joined the NCI DCTD Translational Research Program in May 2016.